Flutamide	NN	B-NP	O	Other	###	1	Flutamide	Flutamide	NN	NN	_	0	root	_	_
in	IN	B-PP	O	Other	###	2	in	in	IN	IN	_	4	case	_	_
the	DT	B-NP	O	Other	###	3	the	the	DT	DT	_	4	det	_	_
treatment	NN	I-NP	O	Other	###	4	treatment	treatment	NN	NN	_	1	nmod	_	_
of	IN	B-PP	O	Other	###	5	of	of	IN	IN	_	6	case	_	_
hirsutism	NN	B-NP	O	Other	###	6	hirsutism	hirsutism	NN	NN	_	4	nmod	_	_
:	:	O	O	Other	###	7	:	:	:	:	_	1	punct	_	_
long-term	JJ	B-NP	O	Other	###	8	long-term	long-term	JJ	JJ	_	10	amod	_	_
clinical	JJ	I-NP	O	Other	###	9	clinical	clinical	JJ	JJ	_	8	dep	_	_
effects	NNS	I-NP	O	Other	###	10	effects	effects	NNS	NNS	_	1	dep	_	_
,	,	O	O	Other	###	11	,	,	,	,	_	10	punct	_	_
endocrine	JJ	B-NP	O	Other	###	12	endocrine	endocrine	JJ	JJ	_	13	amod	_	_
changes	NNS	I-NP	O	Other	###	13	changes	changes	NNS	NNS	_	10	conj	_	_
,	,	O	O	Other	###	14	,	,	,	,	_	10	punct	_	_
and	CC	O	O	Other	###	15	and	and	CC	CC	_	10	cc	_	_
androgen	NN	B-NP	B-protein	B-Protein	###	16	androgen	androgen	NN	NN	_	18	compound	_	_
receptor	NN	I-NP	I-protein	I-Protein	###	17	receptor	receptor	NN	NN	_	18	compound	_	_
behavior	NN	I-NP	O	Other	###	18	behavior	behavior	NN	NN	_	10	conj	_	_
.	.	O	O	Other	###	19	.	.	.	.	_	1	punct	_	_

OBJECTIVE	NN	B-NP	O	Other	###	1	OBJECTIVE	OBJECTIVE	NN	NN	_	0	root	_	_
:	:	O	O	Other	###	2	:	:	:	:	_	1	punct	_	_
To	TO	B-VP	O	Other	###	3	To	To	TO	TO	_	4	mark	_	_
investigate	VB	I-VP	O	Other	###	4	investigate	investigate	VB	VB	_	1	acl	_	_
the	DT	B-NP	O	Other	###	5	the	the	DT	DT	_	7	det	_	_
long-term	JJ	I-NP	O	Other	###	6	long-term	long-term	JJ	JJ	_	7	amod	_	_
effects	NNS	I-NP	O	Other	###	7	effects	effects	NNS	NNS	_	4	dobj	_	_
of	IN	B-PP	O	Other	###	8	of	of	IN	IN	_	9	case	_	_
treatment	NN	B-NP	O	Other	###	9	treatment	treatment	NN	NN	_	7	nmod	_	_
with	IN	B-PP	O	Other	###	10	with	with	IN	IN	_	12	case	_	_
low	JJ	B-NP	O	Other	###	11	low	low	JJ	JJ	_	12	amod	_	_
doses	NNS	I-NP	O	Other	###	12	doses	doses	NNS	NNS	_	9	nmod	_	_
of	IN	B-PP	O	Other	###	13	of	of	IN	IN	_	14	case	_	_
flutamide	NN	B-NP	O	Other	###	14	flutamide	flutamide	NN	NN	_	12	nmod	_	_
on	IN	B-PP	O	Other	###	15	on	on	IN	IN	_	16	case	_	_
clinical	JJ	B-NP	O	Other	###	16	clinical	clinical	JJ	JJ	_	7	nmod	_	_
and	CC	I-NP	O	Other	###	17	and	and	CC	CC	_	16	cc	_	_
hormonal	JJ	I-NP	O	Other	###	18	hormonal	hormonal	JJ	JJ	_	16	conj	_	_
parameters	NNS	I-NP	O	Other	###	19	parameters	parameters	NNS	NNS	_	16	dep	_	_
,	,	O	O	Other	###	20	,	,	,	,	_	16	punct	_	_
as	RB	B-CONJP	O	Other	###	21	as	as	RB	RB	_	16	cc	_	_
well	RB	I-CONJP	O	Other	###	22	well	well	RB	RB	_	21	mwe	_	_
as	IN	I-CONJP	O	Other	###	23	as	as	IN	IN	_	21	mwe	_	_
on	IN	B-PP	O	Other	###	24	on	on	IN	IN	_	28	case	_	_
the	DT	B-NP	O	Other	###	25	the	the	DT	DT	_	28	det	_	_
androgen	NN	I-NP	B-protein	B-Protein	###	26	androgen	androgen	NN	NN	_	28	compound	_	_
receptor	NN	I-NP	I-protein	I-Protein	###	27	receptor	receptor	NN	NN	_	28	compound	_	_
status	NN	I-NP	O	Other	###	28	status	status	NN	NN	_	16	conj	_	_
,	,	O	O	Other	###	29	,	,	,	,	_	16	punct	_	_
in	IN	B-PP	O	Other	###	30	in	in	IN	IN	_	32	case	_	_
hirsute	NN	B-NP	O	Other	###	31	hirsute	hirsute	NN	NN	_	32	compound	_	_
women	NNS	I-NP	O	Other	###	32	women	women	NNS	NNS	_	16	conj	_	_
.	.	O	O	Other	###	33	.	.	.	.	_	4	punct	_	_

DESIGN	NN	B-NP	O	Other	###	1	DESIGN	DESIGN	NN	NN	_	0	root	_	_
:	:	O	O	Other	###	2	:	:	:	:	_	1	punct	_	_
Eighteen	CD	B-NP	O	Other	###	3	Eighteen	Eighteen	CD	CD	_	5	nummod	_	_
hirsute	NN	I-NP	O	Other	###	4	hirsute	hirsute	NN	NN	_	5	compound	_	_
patients	NNS	I-NP	O	Other	###	5	patients	patients	NNS	NNS	_	10	nsubjpass	_	_
with	IN	B-PP	O	Other	###	6	with	with	IN	IN	_	8	case	_	_
regular	JJ	B-NP	O	Other	###	7	regular	regular	JJ	JJ	_	8	amod	_	_
menses	NNS	I-NP	O	Other	###	8	menses	menses	NNS	NNS	_	5	nmod	_	_
were	VBD	B-VP	O	Other	###	9	were	were	VBD	VBD	_	10	auxpass	_	_
studied	VBN	I-VP	O	Other	###	10	studied	studied	VBN	VBN	_	1	dep	_	_
basally	RB	B-ADVP	O	Other	###	11	basally	basally	RB	RB	_	12	advmod	_	_
and	CC	O	O	Other	###	12	and	and	CC	CC	_	10	advmod	_	_
during	IN	B-PP	O	Other	###	13	during	during	IN	IN	_	14	case	_	_
treatment	NN	B-NP	O	Other	###	14	treatment	treatment	NN	NN	_	12	conj	_	_
with	IN	B-PP	O	Other	###	15	with	with	IN	IN	_	18	case	_	_
125	CD	B-NP	O	Other	###	16	125	125	CD	CD	_	17	compound	_	_
mg	NN	I-NP	O	Other	###	17	mg	mg	NN	NN	_	18	amod	_	_
flutamide	NN	I-NP	O	Other	###	18	flutamide	flutamide	NN	NN	_	14	nmod	_	_
,	,	O	O	Other	###	19	,	,	,	,	_	14	punct	_	_
three	CD	B-NP	O	Other	###	20	three	three	CD	CD	_	21	nummod	_	_
times	NNS	I-NP	O	Other	###	21	times	times	NNS	NNS	_	14	appos	_	_
per	IN	B-PP	O	Other	###	22	per	per	IN	IN	_	23	case	_	_
day	NN	B-NP	O	Other	###	23	day	day	NN	NN	_	21	nmod	_	_
for	IN	B-PP	O	Other	###	24	for	for	IN	IN	_	26	case	_	_
12	CD	B-NP	O	Other	###	25	12	12	CD	CD	_	26	nummod	_	_
months	NNS	I-NP	O	Other	###	26	months	months	NNS	NNS	_	21	nmod	_	_
.	.	O	O	Other	###	27	.	.	.	.	_	1	punct	_	_

Barrier	NN	B-NP	O	Other	###	1	Barrier	Barrier	NN	NN	_	6	nsubjpass	_	_
or	CC	I-NP	O	Other	###	2	or	or	CC	CC	_	1	cc	_	_
intrauterine	JJ	I-NP	O	Other	###	3	intrauterine	intrauterine	JJ	JJ	_	1	conj	_	_
contraception	NN	I-NP	O	Other	###	4	contraception	contraception	NN	NN	_	1	conj	_	_
was	VBD	B-VP	O	Other	###	5	was	was	VBD	VBD	_	6	auxpass	_	_
used	VBN	I-VP	O	Other	###	6	used	used	VBN	VBN	_	0	root	_	_
during	IN	B-PP	O	Other	###	7	during	during	IN	IN	_	9	case	_	_
the	DT	B-NP	O	Other	###	8	the	the	DT	DT	_	9	det	_	_
study	NN	I-NP	O	Other	###	9	study	study	NN	NN	_	6	nmod	_	_
in	IN	B-PP	O	Other	###	10	in	in	IN	IN	_	13	case	_	_
sexually	RB	B-NP	O	Other	###	11	sexually	sexually	RB	RB	_	12	advmod	_	_
active	JJ	I-NP	O	Other	###	12	active	active	JJ	JJ	_	13	amod	_	_
women	NNS	I-NP	O	Other	###	13	women	women	NNS	NNS	_	9	nmod	_	_
.	.	O	O	Other	###	14	.	.	.	.	_	6	punct	_	_

Safety	NN	B-NP	O	Other	###	1	Safety	Safety	NN	NN	_	2	compound	_	_
parameters	NNS	I-NP	O	Other	###	2	parameters	parameters	NNS	NNS	_	4	nsubjpass	_	_
were	VBD	B-VP	O	Other	###	3	were	were	VBD	VBD	_	4	auxpass	_	_
assessed	VBN	I-VP	O	Other	###	4	assessed	assessed	VBN	VBN	_	0	root	_	_
throughout	IN	B-PP	O	Other	###	5	throughout	throughout	IN	IN	_	7	case	_	_
the	DT	B-NP	O	Other	###	6	the	the	DT	DT	_	7	det	_	_
study	NN	I-NP	O	Other	###	7	study	study	NN	NN	_	4	nmod	_	_
.	.	O	O	Other	###	8	.	.	.	.	_	4	punct	_	_

Hirsutism	NNP	B-NP	O	Other	###	1	Hirsutism	Hirsutism	NNP	NNP	_	14	nsubjpass	_	_
,	,	O	O	Other	###	2	,	,	,	,	_	1	punct	_	_
graded	VBN	B-VP	O	Other	###	3	graded	graded	VBN	VBN	_	1	acl	_	_
by	IN	B-PP	O	Other	###	4	by	by	IN	IN	_	8	case	_	_
the	DT	B-NP	O	Other	###	5	the	the	DT	DT	_	8	det	_	_
modified	VBN	I-NP	O	Other	###	6	modified	modified	VBN	VBN	_	8	amod	_	_
Ferriman-Gallwey	JJ	I-NP	O	Other	###	7	Ferriman-Gallwey	Ferriman-Gallwey	JJ	JJ	_	8	amod	_	_
score	NN	I-NP	O	Other	###	8	score	score	NN	NN	_	3	nmod	_	_
,	,	O	O	Other	###	9	,	,	,	,	_	1	punct	_	_
and	CC	O	O	Other	###	10	and	and	CC	CC	_	1	cc	_	_
hormonal	JJ	B-NP	O	Other	###	11	hormonal	hormonal	JJ	JJ	_	12	amod	_	_
parameters	NNS	I-NP	O	Other	###	12	parameters	parameters	NNS	NNS	_	1	conj	_	_
were	VBD	B-VP	O	Other	###	13	were	were	VBD	VBD	_	14	auxpass	_	_
evaluated	VBN	I-VP	O	Other	###	14	evaluated	evaluated	VBN	VBN	_	0	root	_	_
basally	RB	B-ADVP	O	Other	###	15	basally	basally	RB	RB	_	16	advmod	_	_
and	CC	O	O	Other	###	16	and	and	CC	CC	_	14	advmod	_	_
at	IN	B-PP	O	Other	###	17	at	at	IN	IN	_	19	case	_	_
4-month	JJ	B-NP	O	Other	###	18	4-month	4-month	JJ	JJ	_	19	amod	_	_
intervals	NNS	I-NP	O	Other	###	19	intervals	intervals	NNS	NNS	_	16	conj	_	_
during	IN	B-PP	O	Other	###	20	during	during	IN	IN	_	21	case	_	_
treatment	NN	B-NP	O	Other	###	21	treatment	treatment	NN	NN	_	19	nmod	_	_
.	.	O	O	Other	###	22	.	.	.	.	_	14	punct	_	_

Gonadotropin-releasing	JJ	B-NP	O	Other	###	1	Gonadotropin-releasing	Gonadotropin-releasing	JJ	JJ	_	2	amod	_	_
hormone	NN	I-NP	O	Other	###	2	hormone	hormone	NN	NN	_	8	nsubjpass	_	_
and	CC	I-NP	O	Other	###	3	and	and	CC	CC	_	2	cc	_	_
ACTH	NN	I-NP	O	Other	###	4	ACTH	ACTH	NN	NN	_	5	compound	_	_
stimulation	NN	I-NP	O	Other	###	5	stimulation	stimulation	NN	NN	_	2	conj	_	_
tests	NNS	I-NP	O	Other	###	6	tests	tests	NNS	NNS	_	2	conj	_	_
were	VBD	B-VP	O	Other	###	7	were	were	VBD	VBD	_	8	auxpass	_	_
performed	VBN	I-VP	O	Other	###	8	performed	performed	VBN	VBN	_	0	root	_	_
before	IN	B-PP	O	Other	###	9	before	before	IN	IN	_	15	nmod	_	_
and	CC	I-PP	O	Other	###	10	and	and	CC	CC	_	15	cc	_	_
after	IN	I-PP	O	Other	###	11	after	after	IN	IN	_	15	conj	_	_
3	CD	B-NP	O	Other	###	12	3	3	CD	CD	_	14	compound	_	_
to	TO	B-PP	O	Other	###	13	to	to	TO	TO	_	14	dep	_	_
4	CD	B-NP	O	Other	###	14	4	4	CD	CD	_	15	nummod	_	_
months	NNS	I-NP	O	Other	###	15	months	months	NNS	NNS	_	8	nmod	_	_
of	IN	B-PP	O	Other	###	16	of	of	IN	IN	_	17	case	_	_
therapy	NN	B-NP	O	Other	###	17	therapy	therapy	NN	NN	_	15	nmod	_	_
.	.	O	O	Other	###	18	.	.	.	.	_	8	punct	_	_

In	IN	B-PP	O	Other	###	1	In	In	IN	IN	_	2	case	_	_
addition	NN	B-NP	O	Other	###	2	addition	addition	NN	NN	_	13	nmod	_	_
,	,	O	O	Other	###	3	,	,	,	,	_	13	punct	_	_
the	DT	B-NP	O	Other	###	4	the	the	DT	DT	_	5	det	_	_
concentration	NN	I-NP	O	Other	###	5	concentration	concentration	NN	NN	_	13	nsubjpass	_	_
of	IN	B-PP	O	Other	###	6	of	of	IN	IN	_	8	case	_	_
androgen	NN	B-NP	B-protein	B-Protein	###	7	androgen	androgen	NN	NN	_	8	compound	_	_
receptors	NNS	I-NP	I-protein	I-Protein	###	8	receptors	receptors	NNS	NNS	_	5	nmod	_	_
in	IN	B-PP	O	Other	###	9	in	in	IN	IN	_	11	case	_	_
mononuclear	JJ	B-NP	B-cell_type	Other	###	10	mononuclear	mononuclear	JJ	JJ	_	11	amod	_	_
leukocytes	NNS	I-NP	I-cell_type	Other	###	11	leukocytes	leukocytes	NNS	NNS	_	5	nmod	_	_
was	VBD	B-VP	O	Other	###	12	was	was	VBD	VBD	_	13	auxpass	_	_
measured	VBN	I-VP	O	Other	###	13	measured	measured	VBN	VBN	_	0	root	_	_
,	,	O	O	Other	###	14	,	,	,	,	_	13	punct	_	_
in	IN	B-PP	O	Other	###	15	in	in	IN	IN	_	18	case	_	_
both	CC	B-NP	O	Other	###	16	both	both	CC	CC	_	18	cc:preconj	_	_
the	DT	I-NP	O	Other	###	17	the	the	DT	DT	_	18	dep	_	_
follicular	JJ	I-NP	O	Other	###	18	follicular	follicular	JJ	JJ	_	13	nmod	_	_
and	CC	I-NP	O	Other	###	19	and	and	CC	CC	_	18	cc	_	_
luteal	JJ	I-NP	O	Other	###	20	luteal	luteal	JJ	JJ	_	18	conj	_	_
phases	NNS	I-NP	O	Other	###	21	phases	phases	NNS	NNS	_	18	dep	_	_
of	IN	B-PP	O	Other	###	22	of	of	IN	IN	_	25	case	_	_
the	DT	B-NP	O	Other	###	23	the	the	DT	DT	_	25	det	_	_
menstrual	JJ	I-NP	O	Other	###	24	menstrual	menstrual	JJ	JJ	_	25	amod	_	_
cycle	NN	I-NP	O	Other	###	25	cycle	cycle	NN	NN	_	18	nmod	_	_
,	,	O	O	Other	###	26	,	,	,	,	_	13	punct	_	_
basally	RB	B-ADVP	O	Other	###	27	basally	basally	RB	RB	_	28	advmod	_	_
and	CC	O	O	Other	###	28	and	and	CC	CC	_	13	advmod	_	_
after	IN	B-PP	O	Other	###	29	after	after	IN	IN	_	31	case	_	_
4	CD	B-NP	O	Other	###	30	4	4	CD	CD	_	31	nummod	_	_
months	NNS	I-NP	O	Other	###	31	months	months	NNS	NNS	_	28	conj	_	_
of	IN	B-PP	O	Other	###	32	of	of	IN	IN	_	34	case	_	_
flutamide	NN	B-NP	O	Other	###	33	flutamide	flutamide	NN	NN	_	34	compound	_	_
treatment	NN	I-NP	O	Other	###	34	treatment	treatment	NN	NN	_	31	nmod	_	_
.	.	O	O	Other	###	35	.	.	.	.	_	13	punct	_	_

RESULTS	NNS	B-NP	O	Other	###	1	RESULTS	RESULTS	NNS	NNS	_	0	root	_	_
:	:	O	O	Other	###	2	:	:	:	:	_	1	punct	_	_
Flutamide	NN	B-NP	O	Other	###	3	Flutamide	Flutamide	NN	NN	_	6	nsubjpass	_	_
was	VBD	B-VP	O	Other	###	4	was	was	VBD	VBD	_	6	auxpass	_	_
well	RB	I-VP	O	Other	###	5	well	well	RB	RB	_	6	advmod	_	_
tolerated	VBN	I-VP	O	Other	###	6	tolerated	tolerated	VBN	VBN	_	1	dep	_	_
in	IN	B-PP	O	Other	###	7	in	in	IN	IN	_	9	case	_	_
all	DT	B-NP	O	Other	###	8	all	all	DT	DT	_	9	det	_	_
women	NNS	I-NP	O	Other	###	9	women	women	NNS	NNS	_	6	nmod	_	_
,	,	O	O	Other	###	10	,	,	,	,	_	6	punct	_	_
with	IN	B-PP	O	Other	###	11	with	with	IN	IN	_	14	case	_	_
the	DT	B-NP	O	Other	###	12	the	the	DT	DT	_	14	det	_	_
noticeable	JJ	I-NP	O	Other	###	13	noticeable	noticeable	JJ	JJ	_	14	amod	_	_
exception	NN	I-NP	O	Other	###	14	exception	exception	NN	NN	_	6	nmod	_	_
of	IN	B-PP	O	Other	###	15	of	of	IN	IN	_	17	case	_	_
one	CD	B-NP	O	Other	###	16	one	one	CD	CD	_	17	nummod	_	_
patient	NN	I-NP	O	Other	###	17	patient	patient	NN	NN	_	14	nmod	_	_
who	WP	B-NP	O	Other	###	18	who	who	WP	WP	_	19	nsubj	_	_
presented	VBD	B-VP	O	Other	###	19	presented	presented	VBD	VBD	_	17	acl:relcl	_	_
increased	VBN	B-NP	O	Other	###	20	increased	increased	VBN	VBN	_	22	amod	_	_
serum	NN	I-NP	B-protein	Other	###	21	serum	serum	NN	NN	_	22	compound	_	_
transaminase	NN	I-NP	I-protein	Other	###	22	transaminase	transaminase	NN	NN	_	19	dobj	_	_
after	IN	B-PP	O	Other	###	23	after	after	IN	IN	_	25	case	_	_
8	CD	B-NP	O	Other	###	24	8	8	CD	CD	_	25	nummod	_	_
months	NNS	I-NP	O	Other	###	25	months	months	NNS	NNS	_	19	nmod	_	_
of	IN	B-PP	O	Other	###	26	of	of	IN	IN	_	27	case	_	_
therapy	NN	B-NP	O	Other	###	27	therapy	therapy	NN	NN	_	25	nmod	_	_
.	.	O	O	Other	###	28	.	.	.	.	_	1	punct	_	_

Hirsutism	NNP	B-NP	O	Other	###	1	Hirsutism	Hirsutism	NNP	NNP	_	3	nsubj	_	_
markedly	RB	B-VP	O	Other	###	2	markedly	markedly	RB	RB	_	3	advmod	_	_
improved	VBN	I-VP	O	Other	###	3	improved	improved	VBN	VBN	_	0	root	_	_
in	IN	B-PP	O	Other	###	4	in	in	IN	IN	_	6	case	_	_
all	DT	B-NP	O	Other	###	5	all	all	DT	DT	_	6	det	_	_
women	NNS	I-NP	O	Other	###	6	women	women	NNS	NNS	_	3	nmod	_	_
during	IN	B-PP	O	Other	###	7	during	during	IN	IN	_	9	case	_	_
the	DT	B-NP	O	Other	###	8	the	the	DT	DT	_	9	det	_	_
treatment	NN	I-NP	O	Other	###	9	treatment	treatment	NN	NN	_	3	nmod	_	_
(	(	O	O	Other	###	10	(	(	(	(	_	12	punct	_	_
Ferriman-Gallwey	JJ	B-NP	O	Other	###	11	Ferriman-Gallwey	Ferriman-Gallwey	JJ	JJ	_	12	amod	_	_
score	NN	I-NP	O	Other	###	12	score	score	NN	NN	_	3	dep	_	_
after	IN	B-PP	O	Other	###	13	after	after	IN	IN	_	15	case	_	_
1	CD	B-NP	O	Other	###	14	1	1	CD	CD	_	15	nummod	_	_
year	NN	I-NP	O	Other	###	15	year	year	NN	NN	_	12	nmod	_	_
:	:	O	O	Other	###	16	:	:	:	:	_	12	punct	_	_
4.1	CD	B-NP	O	Other	###	17	4.1	4.1	CD	CD	_	12	dep	_	_
+/-	CC	I-NP	O	Other	###	18	+/-	+/-	CC	CC	_	17	cc	_	_
0.5	CD	I-NP	O	Other	###	19	0.5	0.5	CD	CD	_	17	conj	_	_
versus	CC	I-NP	O	Other	###	20	versus	versus	CC	CC	_	17	cc	_	_
14.1	CD	I-NP	O	Other	###	21	14.1	14.1	CD	CD	_	17	conj	_	_
+/-	CC	I-NP	O	Other	###	22	+/-	+/-	CC	CC	_	21	cc	_	_
0.9	CD	I-NP	O	Other	###	23	0.9	0.9	CD	CD	_	21	conj	_	_
)	)	O	O	Other	###	24	)	)	)	)	_	12	punct	_	_
.	.	O	O	Other	###	25	.	.	.	.	_	3	punct	_	_

A	DT	B-NP	O	Other	###	1	A	A	DT	DT	_	2	det	_	_
reduction	NN	I-NP	O	Other	###	2	reduction	reduction	NN	NN	_	7	nsubjpass	_	_
of	IN	B-PP	O	Other	###	3	of	of	IN	IN	_	5	case	_	_
serum	NN	B-NP	O	Other	###	4	serum	serum	NN	NN	_	5	compound	_	_
androgens	NNS	I-NP	O	Other	###	5	androgens	androgens	NNS	NNS	_	2	nmod	_	_
was	VBD	B-VP	O	Other	###	6	was	was	VBD	VBD	_	7	auxpass	_	_
found	VBN	I-VP	O	Other	###	7	found	found	VBN	VBN	_	0	root	_	_
,	,	O	O	Other	###	8	,	,	,	,	_	7	punct	_	_
whereas	IN	O	O	Other	###	9	whereas	whereas	IN	IN	_	7	dep	_	_
no	DT	B-NP	O	Other	###	10	no	no	DT	DT	_	11	neg	_	_
change	NN	I-NP	O	Other	###	11	change	change	NN	NN	_	13	nsubjpass	_	_
was	VBD	B-VP	O	Other	###	12	was	was	VBD	VBD	_	13	auxpass	_	_
observed	VBN	I-VP	O	Other	###	13	observed	observed	VBN	VBN	_	7	parataxis	_	_
in	IN	B-PP	O	Other	###	14	in	in	IN	IN	_	16	case	_	_
either	CC	B-NP	O	Other	###	15	either	either	CC	CC	_	16	cc:preconj	_	_
basal	JJ	I-NP	O	Other	###	16	basal	basal	JJ	JJ	_	13	nmod	_	_
or	CC	I-NP	O	Other	###	17	or	or	CC	CC	_	16	cc	_	_
GnRH	JJ	I-NP	O	Other	###	18	GnRH	GnRH	JJ	JJ	_	16	conj	_	_
-	-	O	O	Other	###	19	-	-	-	-	_	16	punct	_	_
stimulated	JJ	I-NP	O	Other	###	20	stimulated	stimulated	JJ	JJ	_	16	conj	_	_
gonadotropins	NNS	I-NP	O	Other	###	21	gonadotropins	gonadotropins	NNS	NNS	_	16	dep	_	_
or	CC	B-PP	O	Other	###	22	or	or	CC	CC	_	16	cc	_	_
in	IN	B-PP	O	Other	###	23	in	in	IN	IN	_	25	case	_	_
the	DT	B-NP	O	Other	###	24	the	the	DT	DT	_	25	det	_	_
cortisol	NN	I-NP	O	Other	###	25	cortisol	cortisol	NN	NN	_	16	conj	_	_
and	CC	O	O	Other	###	26	and	and	CC	CC	_	25	cc	_	_
17	CD	B-NP	O	Other	###	27	17	17	CD	CD	_	28	nummod	_	_
alpha-hydroxyprogesterone	NN	I-NP	O	Other	###	28	alpha-hydroxyprogesterone	alpha-hydroxyprogesterone	NN	NN	_	25	conj	_	_
response	NN	I-NP	O	Other	###	29	response	response	NN	NN	_	25	dep	_	_
to	TO	B-PP	O	Other	###	30	to	to	TO	TO	_	31	case	_	_
ACTH	NN	B-NP	B-protein	Other	###	31	ACTH	ACTH	NN	NN	_	25	nmod	_	_
.	.	O	O	Other	###	32	.	.	.	.	_	7	punct	_	_

Cycles	NNS	B-NP	O	Other	###	1	Cycles	Cycles	NNS	NNS	_	2	nsubj	_	_
remained	VBD	B-VP	O	Other	###	2	remained	remained	VBD	VBD	_	0	root	_	_
ovulatory	JJ	B-ADJP	O	Other	###	3	ovulatory	ovulatory	JJ	JJ	_	2	xcomp	_	_
.	.	O	O	Other	###	4	.	.	.	.	_	2	punct	_	_

Before	IN	B-PP	O	Other	###	1	Before	Before	IN	IN	_	2	case	_	_
treatment	NN	B-NP	O	Other	###	2	treatment	treatment	NN	NN	_	10	nmod	_	_
,	,	O	O	Other	###	3	,	,	,	,	_	10	punct	_	_
the	DT	B-NP	O	Other	###	4	the	the	DT	DT	_	5	det	_	_
number	NN	I-NP	O	Other	###	5	number	number	NN	NN	_	10	nsubj	_	_
of	IN	B-PP	O	Other	###	6	of	of	IN	IN	_	8	case	_	_
androgen	NN	B-NP	B-protein	B-Protein	###	7	androgen	androgen	NN	NN	_	8	compound	_	_
receptors	NNS	I-NP	I-protein	I-Protein	###	8	receptors	receptors	NNS	NNS	_	5	nmod	_	_
was	VBD	B-VP	O	Other	###	9	was	was	VBD	VBD	_	10	cop	_	_
higher	JJR	B-ADJP	O	Other	###	10	higher	higher	JJR	JJR	_	0	root	_	_
in	IN	B-PP	O	Other	###	11	in	in	IN	IN	_	13	case	_	_
the	DT	B-NP	O	Other	###	12	the	the	DT	DT	_	13	det	_	_
luteal	NN	I-NP	O	Other	###	13	luteal	luteal	NN	NN	_	10	nmod	_	_
than	IN	B-PP	O	Other	###	14	than	than	IN	IN	_	18	case	_	_
in	IN	B-PP	O	Other	###	15	in	in	IN	IN	_	18	case	_	_
the	DT	B-NP	O	Other	###	16	the	the	DT	DT	_	18	det	_	_
follicular	JJ	I-NP	O	Other	###	17	follicular	follicular	JJ	JJ	_	18	amod	_	_
phase	NN	I-NP	O	Other	###	18	phase	phase	NN	NN	_	10	advcl	_	_
.	.	O	O	Other	###	19	.	.	.	.	_	10	punct	_	_

This	DT	B-NP	O	Other	###	1	This	This	DT	DT	_	3	det	_	_
rhythmic	JJ	I-NP	O	Other	###	2	rhythmic	rhythmic	JJ	JJ	_	3	amod	_	_
differentiation	NN	I-NP	O	Other	###	3	differentiation	differentiation	NN	NN	_	4	nsubj	_	_
disappeared	VBD	B-VP	O	Other	###	4	disappeared	disappeared	VBD	VBD	_	0	root	_	_
after	IN	B-SBAR	O	Other	###	5	after	after	IN	IN	_	10	mark	_	_
the	DT	B-NP	O	Other	###	6	the	the	DT	DT	_	7	det	_	_
patients	NNS	I-NP	O	Other	###	7	patients	patients	NNS	NNS	_	10	nsubjpass	_	_
had	VBD	B-VP	O	Other	###	8	had	had	VBD	VBD	_	10	aux	_	_
been	VBN	I-VP	O	Other	###	9	been	been	VBN	VBN	_	10	auxpass	_	_
given	VBN	I-VP	O	Other	###	10	given	given	VBN	VBN	_	4	advcl	_	_
the	DT	B-NP	O	Other	###	11	the	the	DT	DT	_	13	det	_	_
antiandrogen	NN	I-NP	O	Other	###	12	antiandrogen	antiandrogen	NN	NN	_	13	compound	_	_
drug	NN	I-NP	O	Other	###	13	drug	drug	NN	NN	_	10	dobj	_	_
.	.	O	O	Other	###	14	.	.	.	.	_	4	punct	_	_

CONCLUSIONS	NNS	B-NP	O	Other	###	1	CONCLUSIONS	CONCLUSIONS	NNS	NNS	_	0	root	_	_
:	:	O	O	Other	###	2	:	:	:	:	_	1	punct	_	_
Flutamide	NN	B-NP	O	Other	###	3	Flutamide	Flutamide	NN	NN	_	5	nsubj	_	_
is	VBZ	B-VP	O	Other	###	4	is	is	VBZ	VBZ	_	5	cop	_	_
effective	JJ	B-ADJP	O	Other	###	5	effective	effective	JJ	JJ	_	1	dep	_	_
in	IN	B-PP	O	Other	###	6	in	in	IN	IN	_	8	case	_	_
the	DT	B-NP	O	Other	###	7	the	the	DT	DT	_	8	det	_	_
treatment	NN	I-NP	O	Other	###	8	treatment	treatment	NN	NN	_	5	nmod	_	_
of	IN	B-PP	O	Other	###	9	of	of	IN	IN	_	10	case	_	_
hirsutism	NN	B-NP	O	Other	###	10	hirsutism	hirsutism	NN	NN	_	8	nmod	_	_
but	CC	O	O	Other	###	11	but	but	CC	CC	_	5	cc	_	_
requires	VBZ	B-VP	O	Other	###	12	requires	requires	VBZ	VBZ	_	5	conj	_	_
constant	JJ	B-NP	O	Other	###	13	constant	constant	JJ	JJ	_	14	amod	_	_
surveillance	NN	I-NP	O	Other	###	14	surveillance	surveillance	NN	NN	_	12	dobj	_	_
of	IN	B-PP	O	Other	###	15	of	of	IN	IN	_	17	case	_	_
liver	NN	B-NP	O	Other	###	16	liver	liver	NN	NN	_	17	compound	_	_
function	NN	I-NP	O	Other	###	17	function	function	NN	NN	_	14	nmod	_	_
.	.	O	O	Other	###	18	.	.	.	.	_	1	punct	_	_

Androgen	NN	B-NP	B-protein	B-Protein	###	1	Androgen	Androgen	NN	NN	_	3	compound	_	_
receptor	NN	I-NP	I-protein	I-Protein	###	2	receptor	receptor	NN	NN	_	3	compound	_	_
blockade	NN	I-NP	O	Other	###	3	blockade	blockade	NN	NN	_	6	nsubjpass	_	_
might	MD	B-VP	O	Other	###	4	might	might	MD	MD	_	6	aux	_	_
be	VB	I-VP	O	Other	###	5	be	be	VB	VB	_	6	auxpass	_	_
potentiated	VBN	I-VP	O	Other	###	6	potentiated	potentiated	VBN	VBN	_	0	root	_	_
by	IN	B-PP	O	Other	###	7	by	by	IN	IN	_	9	case	_	_
a	DT	B-NP	O	Other	###	8	a	a	DT	DT	_	9	det	_	_
reduction	NN	I-NP	O	Other	###	9	reduction	reduction	NN	NN	_	6	nmod	_	_
of	IN	B-PP	O	Other	###	10	of	of	IN	IN	_	12	case	_	_
serum	NN	B-NP	O	Other	###	11	serum	serum	NN	NN	_	12	compound	_	_
androgens	NNS	I-NP	O	Other	###	12	androgens	androgens	NNS	NNS	_	9	nmod	_	_
.	.	O	O	Other	###	13	.	.	.	.	_	6	punct	_	_

Flutamide	NN	B-NP	O	Other	###	1	Flutamide	Flutamide	NN	NN	_	2	nsubj	_	_
affects	VBZ	B-VP	O	Other	###	2	affects	affects	VBZ	VBZ	_	0	root	_	_
androgen	NN	B-NP	B-protein	B-Protein	###	3	androgen	androgen	NN	NN	_	5	compound	_	_
receptor	NN	I-NP	I-protein	I-Protein	###	4	receptor	receptor	NN	NN	_	5	compound	_	_
behavior	NN	I-NP	O	Other	###	5	behavior	behavior	NN	NN	_	2	dobj	_	_
during	IN	B-PP	O	Other	###	6	during	during	IN	IN	_	9	case	_	_
the	DT	B-NP	O	Other	###	7	the	the	DT	DT	_	9	det	_	_
menstrual	JJ	I-NP	O	Other	###	8	menstrual	menstrual	JJ	JJ	_	9	amod	_	_
cycle	NN	I-NP	O	Other	###	9	cycle	cycle	NN	NN	_	2	nmod	_	_
.	.	O	O	Other	###	10	.	.	.	.	_	2	punct	_	_

The	DT	B-NP	O	Other	###	1	The	The	DT	DT	_	2	det	_	_
meaning	NN	I-NP	O	Other	###	2	meaning	meaning	NN	NN	_	6	nsubj	_	_
of	IN	B-PP	O	Other	###	3	of	of	IN	IN	_	5	case	_	_
this	DT	B-NP	O	Other	###	4	this	this	DT	DT	_	5	det	_	_
finding	NN	I-NP	O	Other	###	5	finding	finding	NN	NN	_	2	nmod	_	_
remains	VBZ	B-VP	O	Other	###	6	remains	remains	VBZ	VBZ	_	0	root	_	_
to	TO	I-VP	O	Other	###	7	to	to	TO	TO	_	9	mark	_	_
be	VB	I-VP	O	Other	###	8	be	be	VB	VB	_	9	auxpass	_	_
elucidated	VBN	I-VP	O	Other	###	9	elucidated	elucidated	VBN	VBN	_	6	xcomp	_	_
.	.	O	O	Other	###	10	.	.	.	.	_	6	punct	_	_

